Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
45 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
3SBio Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, '3SBio Inc. - Product Pipeline Review - 2014', provides an overview of the 3SBio Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of 3SBio Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of 3SBio Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of 3SBio Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the 3SBio Inc.'s pipeline products Reasons to buy - Evaluate 3SBio Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of 3SBio Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the 3SBio Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of 3SBio Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of 3SBio Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of 3SBio Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 3SBio Inc. Snapshot 5 3SBio Inc. Overview 5 Key Information 5 Key Facts 5 3SBio Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 3SBio Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 3SBio Inc. - Pipeline Products Glance 13 3SBio Inc. - Late Stage Pipeline Products 13 Phase III Products/Combination Treatment Modalities 13 3SBio Inc. - Clinical Stage Pipeline Products 14 Phase I Products/Combination Treatment Modalities 14 3SBio Inc. - Early Stage Pipeline Products 15 IND/CTA Filed Products/Combination Treatment Modalities 15 Preclinical Products/Combination Treatment Modalities 16 3SBio Inc. - Drug Profiles 17 voclosporin 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 NuPIAO 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Uricase-PEG 20 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 APX-001 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 AT-406 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 DJ-5 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 SSS-08 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 3SBio Inc. - Pipeline Analysis 29 3SBio Inc. - Pipeline Products by Target 29 3SBio Inc. - Pipeline Products by Route of Administration 31 3SBio Inc. - Pipeline Products by Molecule Type 32 3SBio Inc. - Pipeline Products by Mechanism of Action 33 3SBio Inc. - Recent Pipeline Updates 35 3SBio Inc. - Dormant Projects 40 3SBio Inc. - Discontinued Pipeline Products 41 Discontinued Pipeline Product Profiles 41 NuLeusin 41 3SBio Inc. - Company Statement 42 3SBio Inc. - Locations And Subsidiaries 43 Head Office 43 Other Locations & Subsidiaries 43 Appendix 44 Methodology 44 Coverage 44 Secondary Research 44 Primary Research 44 Expert Panel Validation 44 Contact Us 45 Disclaimer 45
List of Tables 3SBio Inc., Key Information 5 3SBio Inc., Key Facts 5 3SBio Inc. - Pipeline by Indication, 2014 8 3SBio Inc. - Pipeline by Stage of Development, 2014 9 3SBio Inc. - Monotherapy Products in Pipeline, 2014 10 3SBio Inc. - Partnered Products in Pipeline, 2014 11 3SBio Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12 3SBio Inc. - Phase III, 2014 13 3SBio Inc. - Phase I, 2014 14 3SBio Inc. - IND/CTA Filed, 2014 15 3SBio Inc. - Preclinical, 2014 16 3SBio Inc. - Pipeline by Target, 2014 30 3SBio Inc. - Pipeline by Route of Administration, 2014 31 3SBio Inc. - Pipeline by Molecule Type, 2014 32 3SBio Inc. - Pipeline Products by Mechanism of Action, 2014 34 3SBio Inc. - Recent Pipeline Updates, 2014 35 3SBio Inc. - Dormant Developmental Projects,2014 40 3SBio Inc. - Discontinued Pipeline Products, 2014 41 3SBio Inc., Other Locations 43 3SBio Inc., Subsidiaries 43
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.